03/11/2025, Monday19:40
flag
Yeni Şafak

EDITION   :

TRTRENENARARFRFRRURUURUR

Third Brazil minister has COVID-19, touts unproven drug cocktail

News Service
16:19, 20/07/2020, Monday
REUTERS
Third Brazil minister has COVID-19, touts unproven drug cocktail
File photo

Brazil's Citizenship Minister Onyx Lorenzoni said on Monday he had tested positive for the new coronavirus, the country's third minister to be infected amid the world's second-worst outbreak.

Lorenzoni, a close ally of President Jair Bolsonaro, credited relatively mild symptoms to an anti-malarial drug touted by the president on social media and at public rallies.

"I already feel the positive effects," the minister wrote on Twitter about his regimen of chloroquine, along with azithromycin and ivermectin, as a treatment against the virus.

Bolsonaro, who is quarantined after he also tested positive for the virus, is taking hydroxychloroquine, a related drug. Both are used to treat malaria, and Bolsonaro has become a full-throated supporter of using them to treat COVID-19, despite the lack of solid proof they work against the disease.

"It is important to remember that the 'off label' use of medication is well established in medicine, as long as the patient clearly agrees," tweeted Bolsonaro on Monday morning, defending the use of hydroxychloroquine for unproven treatments.

On Sunday, Bolsonaro stood a few meters away from rallying supporters in Brasilia and brandished a box of the drug over his head with two hands, drawing cheers, in an online video that commentators likened to a scene from the Lion King movie.

Nearly 80,000 people have died from COVID-19 in Brazil, with more than 2 million cases. Only the United States has fared worse. Experts say the true numbers in Brazil are likely far higher due to a lack of widespread testing.

Augusto Heleno, Bolsonaro's national security advisor, and Mines and Energy Mininster Bento Albuquerque have both tested positive for the virus as well.

The virus has also swept through the political elite in other corners of Latin America, including Bolivia, where the president and more than a half dozen ministers were diagnosed, casting a shadow over an upcoming election.

Comments
Avatar

Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.

Page End
Turkey's Accumulation. International Media Group.

Welcome to the news source that sets Turkey's agenda! With its impartial, dynamic, and in-depth journalism, Yeni Şafak offers its readers an experience beyond current events. Get instant updates on what's happening in Turkey and worldwide, with news spanning a wide range from politics and economy to culture, arts, and sports. Access the most accurate information anytime, anywhere with its digital platforms; keep up with the agenda with Yeni Şafak!

Follow us on social media.
Download Mobile Apps

Carry the agenda in your pocket! With Yeni Şafak's mobile apps, get instant access to the latest news. A wide range of content, from politics to economy, sports to culture and arts, is at your fingertips! Easily download it on your iOS, Android, and Huawei devices to quickly access the most accurate information anytime, anywhere. Download now, don't miss out on developments around the world!

Categories
Albayrak Media

Maltepe Mah. Fetih Cad. No:6 34010 Zeytinburnu/İstanbul, Türkiyeiletisim@yenisafak.com+90 212 467 6515

LEGAL DISCLAIMER

The BIST name and logo are protected under a 'Protection Trademark Certificate' and cannot be used, quoted, or modified without permission. All information disclosed under the BIST name is fully copyrighted by BIST and may not be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.

© Net Medya, All right reserved. 2025

Cookies are used limited to the purposes of the Law on the Protection of Personal Data No. 6698 and in accordance with the legislation. For detailed information, you can review our cookie policy.

Cookie Policy